Next Article in Journal
Evaluation of the Effect of Elite Jojoba Lines on the Chemical Properties of their Seed Oil
Next Article in Special Issue
Caffeic Acid Phenethyl Ester (CAPE) Synergistically Enhances Paclitaxel Activity in Ovarian Cancer Cells
Previous Article in Journal
The Effectiveness of Rhodiola rosea L. Preparations in Alleviating Various Aspects of Life-Stress Symptoms and Stress-Induced Conditions—Encouraging Clinical Evidence
Previous Article in Special Issue
Antitumor Potential of Annona muricata Linn. An Edible and Medicinal Plant in Mexico: In Vitro, In Vivo, and Toxicological Studies
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Phytochemical Composition of Commiphora Oleogum Resins and Their Cytotoxicity against Skin Cancer Cells

1
Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, 89081 Ulm, Germany
2
Laboratoire PhytoChemia, Saguenay, QC G7J 1H4, Canada
3
Department of Pharmacognosy, College of Pharmacy, Cairo University, Cairo 11562, Egypt
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2022, 27(12), 3903; https://doi.org/10.3390/molecules27123903
Submission received: 1 June 2022 / Revised: 15 June 2022 / Accepted: 16 June 2022 / Published: 17 June 2022
(This article belongs to the Special Issue Cytotoxic Activity of Plant Extracts-2nd Edition)

Abstract

:
Oleogum resins of the genus Commiphora have been used in traditional medicines for centuries. More than 200 Commiphora species exhibit highly variable phytochemical compositions. A novel highly selective, sensitive, accurate HPLC-MS/MS method was developed and validated to quantify five characteristic phytosteroids and furanosesquiterpenoids, namely (E)-guggulsterone, (Z)-guggulsterone, curzerenone, furanoeudesma-1,3-diene, and myrrhone. The resulting contents and additionally GC analysis were used to classify and differentiate Commiphora oleogum resins of the species C. myrrha, C. erythraea, C. mukul, C. holtziana, C. confusa, and C. kua, as well as unspecified resins. Interestingly, a Commiphora sample from Ogaden, Ethiopia, comprised 446 ng/mg guggulsterones presumed to be unique to C. mukul from the Indian subcontinent. However, Commiphora from Ogaden differed considerably from C. mukul in respect to guggulsterones isomer’s ratio. Moreover, the cytotoxicity of Commiphora extracts, essential oils, botanical drugs containing Commiphora, and pure compounds against the epidermoid carcinoma A431, malignant melanoma RPMI-7951 and SK-MEL-28 cells was investigated in vitro. Thereby, especially C. mukul extract and C. myrrha essential oil exhibited high cytotoxicity against skin cancer cells with IC50 of 2.9–10.9 µg/mL, but were less toxic to normal keratinocytes. In summary, Commiphora oleogum resins and its phytochemicals warrant further investigation aiming at chemotaxonomical classification as well as application in skin cancer treatment.

Graphical Abstract

1. Introduction

The species of genus Commiphora Jacq. of the Burseraceae family are shrubs or small trees with thorny branches and aromatic oleogum resin exudates with characteristic odors (Figure 1a) [1]. The genus Commiphora comprises more than 200 species mainly distributed in northeastern Africa, southern Arabia, and India [2]. Oleogum resins from Commiphora species consist of 30–60% water-soluble fraction containing proteins and polysaccharides, 3–8% essential oil, and 25–40% alcohol-soluble resin containing terpenes, steroids, and sterols [1,3]. In traditional African, Arabian, Indian, and Chinese medicine Commiphora oleogum resins have been used for centuries for the treatment of wounds and fractures, against arthritis, obesity, parasitic infections, various gastrointestinal diseases, and as painkillers [4]. Already 2000 BC, Atharva Veda, an ancient Ayurvedic script, describes Commiphora oleogum resin as an effective herbal drug [5]. In modern western medicine, Commiphora oleogum resins are being mainly used as myrrh tincture for local treatment of mild inflammatory processes in the mouth and throat such as gum inflammation or dental pressure sores [2]. Accordingly, different medications containing Commiphora oleogum resins can be found on the market, such as Myrrhinil-Intest® intended to treat gastrointestinal disorders or Gugulipid® marketed as antihyperlipidemic drug.
The most known Commiphora oleogum resin is “myrrh”, obtained from trees of C. myrrha (Nees) Engl. (syn. C. molmol Engl.) predominantly growing in Somalia [2]. Further types of well-known Commiphora oleogum resins are “opopanax” (or “bisabol myrrh”) from C. erythraea (Ehrenb.) Engl. and “african opopanax” from C. kataf (Forssk.) Engl., both mainly widespread in Somalia and Kenya, as well as “guggul” (or “false myrrh”) from C. mukul (Hook ex. Stocks) Engl. grown in India [1]. Furthermore, several other Commiphora species in Africa and Arabia produce oleogum resins called inter alia “bdellium” or “hagar”, which resemble “myrrh” [1,2]. However, due to a deciduous habit, mainly dioecious breeding system, and a tendency to develop flowers prior to leaves, the systematic assignment of individual Commiphora trees is hampered [6].
More than 300 phytochemical molecules, such as mono-, sesqui-, di- and triterpenes, as well as steroids, were identified in oleogum resins of genus Commiphora. Here, sesquiterpenoids and furanosesquiterpenoids are of particular interest since they not only account for the characteristic “myrrh” odors but also exhibit antibacterial, antifungal, and antiviral activities [4,7]. Another promising substance group found in Commiphora are phytosteroids, especially guggulsterones, so far exclusively found in C. mukul. Guggulsterones exist as two stereoisomers differing only in cis-trans isomerism at position C-17, namely (E)-guggulsterone and (Z)-guggulsterone (Figure 1b). Guggulsterones are known for inhibition of the farnesoid X receptor (FXR), a nuclear hormone receptor activated by bile acids [8]. Hence, C. mukul extracts containing guggulsterones have been attributed a hypolipidemic activity by decreasing the low density lipoprotein (LDL) synthesis in the liver [9]. However, several clinical studies indicated no clear support of the above claim and no significant efficiency in the treatment of hyperlipidemia [10,11].
In Ayurvedic medicine, Commiphora oleogum resins and their essential oils have been recognized for centuries for their anti-inflammatory activity [12]. In 1985, the anti-inflammatory and antipyretic effect of C. myrrha oleogum resin was confirmed in carrageenan-induced paw edema in rats [13]. Further studies revealed underlying mechanisms of the anti-inflammatory activity of Commiphora oleogum resins, such as inhibition of the transcriptional factor NF-κB pathway by guggulsterones and furanosesquiterpenoids [14,15]. This initiated further trials aiming at treatment of chronic inflammatory diseases such as rheumatoid arthritis, osteoarthritis, and inflammatory bowel diseases. Thus, a clinical trial showed that the herbal preparation containing C. myrrha was safe and similarly effective to the standard therapy with mesalazine in the treatment of colitis ulcerosa [16].
NF-κB is not only responsible for inflammatory processes but also for regulation of antiapoptotic genes. Accordingly, Commiphora oleogum resins were shown to exhibit cytotoxicity against several cancer cell lines [15,17,18]. However, so far, little is known about the effect of Commiphora oleogum resins and their phytochemicals against skin cancer cells. With an annual increase of approximately one million new cases, skin cancer (including melanoma and non-melanoma skin cancer) became one of the most common malignant disease with 4.5% of all new cancer cases [19]. As standard chemotherapies of metastatic skin cancer are often associated with severe side effects, there is considerable interest in the development of alternative and selective therapeutic methods based, among others, on compounds from natural sources [19].
The aim of this study was to investigate and compare Commiphora oleogum resins of different species and from various locations as well as botanical drugs containing Commiphora oleogum resins, Myrrhinil-Intest® and Gugulipid®, regarding their phytochemical composition and their cytotoxic activity against different skin cancer cell lines. Information about Commiphora’s chemodiversity could serve as basis for chemotaxonomic differentiation of Commiphora species as well as for rational selection of natural sources for future drug development.

2. Results and Discussion

2.1. HPLC-MS/MS Method Development and Validation

For simultaneous quantitative analysis of (E)-guggulsterone, (Z)-guggulsterone, curzerenone, furanoeudesma-1,3-diene, and myrrhone in Commiphora oleogum resins and preparations, a novel, highly sensitive, accurate, and precise HPLC-MS/MS method was developed and validated.

2.1.1. MS/MS Analysis

(E)-guggulsterone and (Z)-guggulsterone analyzed by mass spectrometry in the positive ionization mode exhibited very similar mass spectra (Figure S1). Thus, both guggulsterone isomers exhibited m/z 313 for [M + H]+ as molecular ion base peaks. Furthermore, both analytes showed the same most abundant molecular ion adducts with m/z 335 for [M + Na]+, m/z 625 for [2M + H]+, and m/z 647 for [2M + Na]+. Moreover, fragmentation of the precursor ion m/z 313 resulted in the same characteristic product ions m/z 97 and m/z 109 for both guggulsterone isomers. Hence, a selective quantification of individual guggulsterones by mass spectrometry without prior chromatographic separation was not possible. In contrast to positive ionization, negative ionization resulted in no characteristic signals distinguishable from the noise. The higher ionizability in the positive ionization mode can notably be explained by stabilization of positive charged ion by positive inductive effects (+I), hyperconjugation, negative mesomeric effects (-M) of guggulsterone’s α,β-unsaturated carbonyl groups.
Unlike guggulsterones, the investigated furanosesquiterpenoids were clearly distinguishable by mass spectrometry. Analysis in the positive ionization mode exhibited characteristic molecular ion base peaks [M + H]+ of m/z 231 for curzerenone, m/z 215 for furanoeudesma-1,3-diene, and m/z 229 for myrrhone (Figure S2). Collision induced dissociation (CID) resulted in characteristic product ions, which were used for selective and sensitive quantification.

2.1.2. Optimization of Chromatographic Parameters by Design of Experiments

Since (E)-guggulsterone and (Z)-guggulsterone are geometric isomers with identical molar mass, a selective quantification must be ensured by chromatographic separation. For this purpose, a novel HPLC method was developed. Here, on basis of preliminary tests and previous studies, C18 reverse phases were used [20,21,22]. To ensure a sufficient separation of the guggulsterone isomers within a short run time, the chromatographic parameters were optimized by Design of Experiment (DoE). Here, a three-factorial central composite design was used, with the starting concentration of eluent B (variable A), the slope of the gradient (variable B), and the flow rate (variable C) as independent variables (Table S1). To optimize the chromatographic method regarding selectivity and run time, the chromatographic resolution R and the mean analyte’s retention time Ø tR were used as dependent response variables. Here, R and Ø tR were calculated with following formulas:
R = 1.18 × t R ( ( Z )-Guggulsterone ) t R ( ( E )-Guggulsterone ) w 0.5 ( ( Z )-Guggulsterone ) +   w 0.5 ( ( E )-Guggulsterone )
and
Ø   t R = t R ( ( Z )-Guggulsterone ) +   t R ( ( E )-Guggulsterone ) 2 ,
with tR, the respective retention time and w0.5, the respective peak width at half-height. A chromatographic resolution R ≥ 1.5 was considered as sufficient peak separation for selective quantification of the individual guggulsterones [23].
Analysis of the effects revealed that only variables A and B had a significant effect on R, whereas variables A, B, and C had a significant effect on Ø tR. Additionally, evaluation of the DoE led to following regression equation:
R ( A , B , C ) = 4.71 0.0246   A 0.680   B + 4.90   C 0.000292   ( A × A ) 0.0336   ( B × B ) 0.870   ( C × C ) + 0.0112   ( A × B ) 0.0564   ( A × C ) + 0.048   ( B × C )
and
Ø   t R ( A , B , C ) = 70.4 0.781   A 9.85   B + 42.9   C + 0.00105   ( A × A ) + 0.410   ( B × B ) + 20.3   ( C × C ) + 0.0967   ( A × B ) + 0.119   ( A × C ) + 1.34   ( B × C )
with variables A, B, and C and uncoded values.
Since all experiments, except for experiment #10, resulted in sufficient chromatographic resolution of the analytes, the retention times were further optimized. Here, experiment #8 showed the shortest mean retention time Ø tR < 5 min (Figure 2). Therefore, the parameters of experiment #8 were used for the development of the final analytical method, as they ensured a sufficient chromatographic separation concurrent with a rapid run time.

2.1.3. Validation of Methanolic Extraction and HPLC-MS/MS Analysis

To ensure a simultaneous, selective, accurate, and sensitive quantification of guggulsterones and furanosesquiterpenoids, the extraction and analysis method was validated in terms of efficiency, linearity, precision, recovery, limit of detection (LOD), and limit of quantification (LOQ).
Based on previous studies investigating analytes with related chemical structures, methanol was selected as extraction solvent [24]. Moreover, an extraction with methanol ensured an optimal compatibility of the obtained extracts and the chromatographic eluents. A careful maceration at room temperature guaranteed a non-destructive extraction of sensitive and thermolabile compounds. To achieve an exhaustive extraction, the methanolic extraction was performed repetitively with several extraction cycles. Analysis of guggulsterone contents after up to six extraction cycles showed that already three extraction cycles sufficiently extracted 99.64 ± 0.11% of (E)-guggulsterone and 99.72 ± 0.07% of (Z)-guggulsterone from C. mukul oleogum resin (n = 3, guggulsterone contents after six extraction cycles = 100%). Hence, a methanolic extraction with three repetitive extraction cycles was considered as exhaustive. Guggulsterones were used for investigation of extraction efficiency, because their lipophilicity (logP(guggulsterones) = 2.382 ± 0.287) lies in between all analytes (logP(curzerenone) = 0.315 ± 0.613, logP(myrrhone) = 1.661 ± 1.324, and logP(furanoeudesma-1,3-diene) = 5.366 ± 0.369) [25].
The linear dynamic range (LDR) is a key parameter of quantitative HPLC-MS/MS methods [26]. LDR for all analytes was investigated by external calibration and Mandel’s fitting test. Here, LDR passed the linearity test in a range of 1–1000 ng/mL for both guggulsterones, curzerenone, and myrrhone. Concentrations above 1000 ng/mL exhibited no linear concentration-response ratio due ion detector saturation. Sensitivity, such as limit of detection (LOD) and limit of quantification (LOQ), were calculated based on the standardization criteria of DIN 32645 as defined by the German standardization committee (Table 1) [27]. Here, for a sample with concentration β = 10 mg/mL, the corresponding LODs were obtained: 0.20 ng (E)-guggulsterone per mg oleogum resin (200 ppt), 0.18 ng (Z)-guggulsterone per mg oleogum resin (180 ppt), 0.16 ng curzerenone per mg oleogum resin (160 ppt), and 0.23 ng myrrhone per mg oleogum resin (230 ppt). However, sensitivity of furanoeudesma-1,3-diene was approximately about a factor 1000 poorer compared to other analytes. Furanoeudesma-1,3-diene exhibited a LDR in a range of 0.1–500 µg/mL and a LOD of 230 ng per mg oleogum resin (230 ppb) for a corresponding sample concentration of β = 10 mg/mL. In contrast to curzerenone and myrrhone, the carbonyl group is missing in the chemical structure of furanoeudesma-1,3-diene yielding a poorer ionization efficiency by electrospray ionization (ESI). Here, an ionization by atmospheric-pressure chemical ionization (APCI) or analysis by gas chromatography (GC) would lead to higher sensitivity. Precision of guggulsterone and furanosesquiterpenoid analysis was investigated at two concentration levels with n = 5 for intraday precision and n = 4 for interday precision (Table 2). Here, intraday precisions with relative standard deviations (RSD) of 1.4–4.2% and interday precisions with RSD 0.7–6.6% were determined. The accuracy was investigated by recovery analysis of standards in oleogum resin matrices. Therefore, a C. mukul and a C. holtziana extract were spiked at three levels by standard addition. The recoveries of guggulsterone were 99.9 ± 1.5% for (E)-guggulsterone and 99.8 ± 0.7% for (Z)-guggulsterone. In addition, recovery of curzerenone was 100.8% ± 1.5%, recovery of furanoeudesma-1,3-diene was 98.5 ± 3.9%, and recovery of myrrhone was 101.9 ± 0.4%.

2.2. Preparation of Commiphora Oleogum Resin Extracts and Essential Oils

Commiphora oleogum resins were extracted exhaustively by repetitive methanolic maceration yielding 26.7% (w/w) C. myrrha extract, 79.8% (w/w) C. erythraea extract, 29.8% (w/w) C. mukul extract, 53.7% (w/w) C. kataf extract, 22.6% (w/w) C. holtziana extract, 75.4% (w/w) C. confusa extract, and 74.5% (w/w) C. kua extract. Additionally, two unknown Commiphora oleogum resins from the Tarraxo region in Somalia and the Ogaden region in Ethiopia were investigated yielding 17.4% (w/w) and 28.8% (w/w) extracts, respectively. Whereas the oleogum resin of C. confusa resulted in a light brown crystalline extract, all other oleogum resins resulted in oily extracts with a light brown to dark brown color.
Commiphora essential oils were obtained by hydrodistillation of the respective oleogum resins. The hydrodistillation yielded 2.2% (w/w) C. myrrha essential oil, 3.0% (w/w) C. erythraea essential oil, 1.2% (w/w) C. mukul essential oil, 3.3% (w/w) C. kataf essential oil, 1.0% (w/w) C. holtziana essential oil, 4.2% (w/w) C. confusa essential oil, and 0.06% (w/w) C. kua essential oil. Hydrodistillation of the Commiphora oleogum resin from Ogaden resulted in 2.1% (w/w) essential oil. However, by hydrodistillation of the Commiphora oleogum resin from Tarraxo, no essential oil could be obtained despite of an exhaustive distillation process.

2.3. Chemical Composition of Commiphora Oleogum Resins and Commiphora Botanical Drugs

After extraction, the Commiphora extracts were analyzed by HPLC-MS/MS regarding their contents of guggulsterones and furanosesquiterpenoids (Table S2). The obtained concentrations were corrected by means of the respective extraction yields resulting in (E)-guggulsterone, (Z)-guggulsterone, curzerenone, furanoeudesma-1,3-diene, and myrrhone contents of the individual oleogum resins (Table 3). Moreover, Commiphora essential oils obtained by hydrodistillation of the respective oleogum resins were analyzed by gas chromatography coupled to flame ionization detection (GC-FID) with complementary use of mass spectrometry (GC-MS) for identification purposes (Table 4).

2.3.1. Commiphora myrrha (Nees) Engl.

C. myrrha (syn. C. molmol Engl.) is mainly distributed in Somalia and produces an oleogum resin described as “true myrrh”, “hirabol/heerabol myrrh”, or “molmol”. The word myrrh derives from the Arabian word “murr” which means bitter, while the Somali word “molmol” means very bitter [1,2].
HPLC-MS/MS analysis revealed furanoeudesma-1,3-diene with 87.7 µg/mg as the most abundant compound of C. myrrha oleogum resin (Figure S3a). In addition to furanoeudesma-1,3-diene, C. myrrha contained small amounts of curzerenone and myrrhone (Figure 3a). However, the steroids (E)-guggulsterone and (Z)-guggulsterone were not detectable. Analysis of essential oil in C. myrrha oleogum resin by GC demonstrated that its main components are curzerene, β-elemene, lindestrene, and, in agreement with the HPLC-MS/MS analysis, furanoeudesma-1,3-diene (Table 4).
The particularly high contents of furanoeudesma-1,3-diene in C. myrrha were confirmed by other studies and enable a differentiation between C. myrrha and C. erythraea which distribution areas overlap [28]. The typical myrrh odor is mainly attributed to a mixture of furanoeudesma-1,3-diene and lindestrene [3].

2.3.2. Commiphora erythraea (Ehrenb.) Engl.

Similar to C. myrrha, C. erythraea (var. glabrescens Engl.) is mostly found in northeastern Africa, such as Somalia, Eritrea, and Kenya. The oleogum resin obtained from C. erythraea is called “opopanax”, “bisabol myrrh”, or “perfumed bdellium”. Wheres C. myrrha represents the major source of myrrh today, C. erythraea was predominantly used in ancient times [2,29].
C. erythraea oleogum resin contains moderate amounts of the furanosesquiterpenoids curzerenone (1.7 µg/mg) and myrrhone (0.6 µg/mg) and no furanoeudesma-1,3-diene (Figure 3b), which corresponds well to the literature [30]. Furthermore, no guggulsterones could be found in C. erythraea oleogum resin. The essential oil from C. erythraea contained mainly curzerene, β-elemene, β-bourbonene, and (Z)-α-bisabolene, but was also deficient in furanoeudesma-1,3-diene (Table 4). For this species, especially (Z)-α-bisabolene contributes to the typical odor of “opopanax” [1,31].
As mentioned before, the absence of furanoeudesma-1,3-diene allows a distinction from C. myrrha. This is of particular interest, as C. erythraea is frequently used as adulteration for C. myrrha [1,28].

2.3.3. Commiphora mukul (Hook. ex Stocks) Engl.

Unlike most Commiphora species, C. mukul (syn. C. wightii (Arnott.) Bhandari) is found extensively in East India, Bangladesh, and Nepal. Oleogum resins from C. mukul also known as “guggul”, “false myrrh”, or “bdellium” were used for centuries in Ayurveda, the traditional Indian medicine [1,2,5].
HPLC-MS/MS analysis demonstrated that, different to other Commiphora species, guggulsterones are present in C. mukul oleogum resin, while it contains no furanosesquiterpenoids (Figure 3c and Figure 4). Thus, 1.1 µg/mg (E)-guggulsterone and 2.5 µg/mg (Z)-guggulsterone are present in C. mukul oleogum resin with the ratio (E)-guggulsterone to (Z)-guggulsterone (Rguggulsterone(E/Z)) equal to 0.43. This correlates well with the evaluation of the data from Ahmed et al. [20], revealing an average Rguggulsterone(E/Z) of 0.46 (n = 22 C. mukul oleogum resins). In contrast to all other Commiphora essential oils investigated, C. mukul contained mainly Δ3-carene and longifolene (Table 4), which is quite unique for an essential oil.

2.3.4. Commiphora kataf (Forssk.) Engl.

The species C. kataf is predominately distributed in Kenya and produces an oleogum resin called “african opopanax” [1,2].
Analysis of C. kataf olegum resin revealed a similar furanosesquiterpenoid composition to that of C. erythraea but a significant higher content of myrrhone (Figure 3d). In fact, C. kataf exhibited the highest content of myrrhone of all samples investigated. Furthermore, C. kataf essential oil comprises β-elemene, δ-elemene, and germacrene D as major compounds (Table 4).

2.3.5. Commiphora holtziana Engl.

The species C. holtziana, similar to C. kataf, is growing mainly in Kenya. Oleogum resins obtained from C. holtziana are known as “haggar” or “hagar” and are used by the indigenous peoples as acaricide against ticks [32,33].
HPLC-MS/MS analysis revealed amounts of curzerenone, furanoeudesma-1,3-diene, and myrrhone in C. holtziana (Figure 5) similar to those found in C. myrrha. However, in contrast to C. myrrha, C. holtziana exhibited a varying furanosesquiterpenoid composition with a lower content of furanoeudesma-1,3-diene and higher contents of curzerenone and myrrhone (Figure 3e). Additionally, essential oil from C. holtziana contained a higher proportion of furanoeudesma-1,3-diene than C. myrrha (Table 4). Still in general, chemical composition of C. holtziana and C. myrrha were very similar, impeding a chemotaxonomical differentiation between these two species.

2.3.6. Commiphora confusa Vollesen

C. confusa is one of the lesser known Commiphora species. It grows in Kenya and Ethiopia, where it is used in traditional medicine for treatment of microbial infections [34,35].
Interestingly, in contrast to all other oleogum resins which produced oily extracts, alcoholic extract of C. confusa is crystalline, similar to those obtained from Boswellia species [24]. C. confusa oleogum resin contained only a small amount of curzerenone (4 ng/mg). In addition, neither furanoeudsma-1,3-diene nor myrrhone nor guggulsterones could be found in C. confusa (Figure 3f). The C. confusa essential oil consisted mainly of α-pinene, β-pinene, α-thujene, and para-cymene (Table 4), which is similar to essential oils from Boswellia species [23,34].
Oleogum resins from C. confusa are often blended with resins from Boswellia neglecta and are sold as frankincense, Boswellia oleogum resin [34]. For this reason, we have additionally analyzed the sample for boswellic and lupeolic acids, characteristic lead compounds of the genus Boswellia [24]. Analysis of ten different boswellic and lupeolic acids by HPLC-MS/MS showed that neither of the investigated analytes was present in the C. confusa sample ascertaining that the investigated oleogum resin is pure and was not blended with Boswellia oleogum resins.

2.3.7. Commiphora kua (R.Br. ex Royle) Vollesen

C. kua grows in northeastern Africa and southern Arabia, especially on the island Socotra belonging to Yemen. The plant and its oleogum resins are used in traditional herbal medicine for the treatment of snakebites, gonorrhea, and gastric disorders [36].
The analysis of C. kua oleogum resin demonstrated the absence of the furanosesquiterpenoiods and guggulsterones investigated (Figure 3g). Likewise, no boswellic acids could be found indicating no contamination with Boswellia species. According to previous studies, octanordammarane triterpenes namely mansumbinome and mansumbinol are characteristic compounds of C. kua and could be used for its identification [32]. Furthermore, GC analysis of the essential oil revealed the sesquiterpenoids γ-cadinene, τ-cadinol, and β-caryophyllene as characteristic components of C. kua essential oil (Table 4). These results correspond with previous studies [37] and clearly differentiate C. kua from other Commiphora species.

2.3.8. Commiphora Oleogum Resins from Tarraxo and Ogaden

In addition, two further Commiphora oleogum resins were investigated whose taxonomic assignments were unclear. One of the samples was from Tarraxo, a spring in the Bari region of Somalia. Interestingly, this oleogum resin showed the highest content of curzerenone (9.5 µg/mg), only a small amount of myrrhone (30 ng/mg), and no furanoeudesma-1,3-diene or guggulsterones (Table 3, Figure 3h). Published data demonstrate that similarly high contents of curzerenone and a concurrent lack of furanoeudesma-1,3-diene is characteristic for the species C. sphaerocarpa Chiow. [1,32]. Hydrodistillation of the oleogum resin from Tarraxo did not yield any essential oil impeding additional phytochemical analysis of the sample.
Another unidentified Commiphora oleogum resin sample was harvested in the Ogaden region of Ethiopia. Interestingly, this samples contained 0.27 µg/mg (E)-guggulsterone and 0.17 µg/mg (Z)-guggulsterone, as well as 2.2 µg/mg curzerenone and 0.87 µg/mg myrrhone (Table 4). Thus, this was the only Commiphora oleogum resin that contained guggulsterones together with furanosesquiterpenoids (Figure 3i). Guggulsterones are considered biomarkers specific for C. mukul typically grown at the Indian subcontinent as we have shown in Table 4 and Figure 3c. Yet, C. mukul trees, though rarely, could be also found in Africa [1,2,15]. Still, in C. mukul (Z)-guggulsterone is quantitatively dominant over (E)-guggulsterone (Table 4) and [22]. However, the sample from Ogaden exhibited a considerably higher proportion of (E)-guggulsterone than (Z)-guggulsterone with a ratio Rguggulsterone(E/Z) = 1.57 indicating that the oleogum resin was not obtained from C. mukul. Furthermore, GC analysis of the essential oil revealed curzerene, β-elemene, germacrene D, germacrene B, and γ-elemene as major components (Table 4). In fact, the sample could possibly be obtained from C. africana (Arn.) Engl. growing in Ethiopia, the oleogum resin of which is locally called, similar to C. mukul, “bdellium” or “false myrrh” [2]. An alternative origin of the resin could be the species C. ogadensis Chiov. (syn. C. hildebrandtii Engl.) which is especially distributed, as the name suggests, in the Ogaden region between Ethiopia and Somalia. About both species relatively little is known and their comprehensive phytochemical analysis remains to be carried out.

2.3.9. Commiphora Botanical Drugs

Additionally, two botanical drugs containing Commiphora oleogum resin or extract, namely Myrrhinil-Intest® and Gugulipid® were investigated.
Myrrhinil-Intest® is intended for use against gastrointestinal disorders, such as non-specific diarrhea, mild cramps, or flatulence. It contains chamomile flower extract (70 mg/pill), coffee charcoal (50 mg/pill), and powered C. molmol (syn. C. myrrha) oleogum resin (100 mg/pill) [16]. HPLC-MS/MS analysis revealed presence of curzerenone, furanodeusma-1,3-diene, and myrrhone as well as lack of guggulsterones, which corresponds well with the C. myrrha analysis. However, Myrrhinil-Intest® contained with 0.456 µg/mg considerably less furanoeudesma-1,3-diene than the crude C. myrrha oleogum resin (87.7 µg/mg) (Figure 3a).
Gugulipid® is considered a hypolipidemic drug containing an ethyl acetate extract of C. mukul [9]. Chemical analysis revealed a total guggulsterone content of 19.5 µg/mg which is slightly below the content quoted by the manufacturer (2.5% guggulsterones). Furthermore, (Z)-guggulsterone is the dominant isomer over (E)-guggulsterone with Rguggulsterone(E/Z) = 0.61, which corresponds to the natural guggulsterone proportion in C. mukul [20,22].

2.4. Cytotoxic Efficacy of Commiphora Extracts against Skin Cancer Cells

Next, cytotoxic effects of Commiphora oleogum resin extracts and essential oils against the epidermoid carcinoma cell line A431 and the malignant melanoma cells lines RPMI-7951 and SK-MEL-28 were compared. The cell lines selected are rather resistant to treatment with the standard chemotherapeutic drugs cisplatin and 5-fluorouracil (Table 5). The Commiphora extracts concentration-dependently inhibited the viability of A431 cells with half maximal inhibitory concentrations (IC50) between 8.4 and 21.4 µg/mL. Furthermore, Commiphora extracts were toxic for RPMI-7951 and SK-MEL-28 with IC50 = 2.9–11.5 µg/mL and IC50 = 10.9–23.4 µg/mL, respectively, which is comparable or even higher (particularly for SK-MEL-28 cells) than the cytotoxicity of cisplatin and 5-fluorouracil. Interestingly, the extracts obtained from C. mukul exhibited the highest cytotoxicity against all cell lines investigated. Statistical analysis confirmed higher cytotoxic efficacy of a C. mukul extract compared to extracts from C. erythraea, C. holtziana, C. kua, and C. from Tarraxo (ANOVA and post hoc by Dunett’s test, Figure S4).
Likewise, essential oils of Commiphora oleogum resins exhibited similar cytotoxic activity against the skin cancer cell lines (Table 5). Essential oils from C. myrrha, C. erythraea, and C. holtziana exhibited the highest toxicity to all three skin cancer cell lines tested. Characteristic for these three samples is the presence of the sesquiterpenoids β-elemene and curzerene. β-Elemene is known to inhibit proliferation and angiogenesis and induce apoptosis in several cancer cell lines in vitro and in vivo and to exhibit lower toxicity against normal cells [38]. In China, the β-elemene-rich plant Curcuma wenyujin is used in traditional Chinese medicine (TCM) to treat various conditions including cancers [39]. Particularly, intratumoral injections of β-elemene are used in clinical practice in China for anticancer treatment, though, the quality of scientific evidence supporting such treatment is insufficient [40]. Curzerene, present in relatively high proportions in C. myrrha, C. erythraea, and C. holtziana essential oils was shown to exhibit antiproliferative, proapoptotic and cytotoxic effect on human lung adenocarcinoma cells in vitro and in cancer xenografts in mice [41].
The most active samples such as C. mukul extract and C. myrrha essential oil were additionally tested for their cytotoxicity against non-carcinogenous human keratinocytes (MBU-IM). Here, the C. mukul extract and C. myrrha essential oil were less toxic to normal human keratinocytes than to malignant melanoma cells indicating their selectivity towards cancer cells (Figure 6).
Guggulsterones are characteristic biologically active components of C. mukul which distinguish it from other Commiphora species. Thus, (Z)-guggulsterone have been shown to induce caspase-dependent apoptosis in prostate cancer cells at concentrations > 10 µM [18]. Furthermore, guggulsterones inhibit the activation of NF-κB and, thus, suppress the expression of antiapoptotic genes [15]. Hence, the cytotoxic efficacies of both isomers against skin cancer cells were investigated. Here, (E)-guggulsterone exhibited cytotoxic effect on all three cancer cells lines with an IC50 = 12.6 µg/mL for A431, an IC50 = 3.7 µg/mL for RPMI-7951, and an IC50 = 11.1 µg/mL for SK-MEL-28. Similarly, (Z)-guggulsterone was also cytotoxic with an IC50 = 18.9 µg/mL for A431, an IC50 = 6.4 µg/mL for RPMI-7951, and an IC50 = 10.7 µg/mL for SK-MEL-28 (Table 5). However, the cytotoxicity of the C. mukul extract could not solely be traced back to the cytotoxic effects of the individual guggulsterones, because their contents in C. mukul extract are relatively low (Table S2).
Because C. mukul contains both guggulsterones, potential synergistic effects of (E)- and (Z)-guggulsterone with regard to their toxicity against skin cancer cell lines were investigated. The combination index (CI) [42,43], a quantitative measure of the degree of drug interaction in terms of additive effect (defined as CI = 1), synergism (CI < 1), or antagonism (CI > 1) on cell viability was used to characterize guggulsterone interactions. When applied together, (E)- and (Z)-guggulsterones exhibited slight to moderate antagonistic interactions at effective doses ED50, ED75, and ED90. The only moderate synergistic interaction was observed in RPMI-7951 at ED50 (Table 6). This indicates that in addition to guggulsterones, C. mukul should contain additional cytotoxic compounds. This is also supported by the data demonstrating that Gugulipid® containing more guggulsterones than the C. mukul extract exhibited a significantly lower cytotoxicity against all skin cancer cells investigated (p < 0.001 for A431 and SK-MEL-28 and p = 0.002 for RPMI-7951, Student’s t-test). In addition to guggulsterones, C. mukul contains a further steroid substance group, termed guggulsterols [44]. However, their biological and pharmacological properties have not been investigated yet.

3. Materials and Methods

3.1. Materials and Samples

All solvents and chemicals were of analytical reagent grade. The solvents used for the extraction, sample preparation, and HPLC-MS/MS analysis were MeOH, acetic acid (both HiPerSolv Chromanorm, VWR chemicals, Fontenay-sous-Bois, France), and ultrapure water (reverse-osmosis type water (pureAqua, Schnaitsee, Germany) coupled to an Arium Pro station (Sartorius, Göttingen, Germany). The compounds (E)-guggulsterone, (Z)-guggulsterone, curzerenone, and furanoeudesma-1,3-diene were purchased from Sigma-Aldrich (St. Louis, MO, USA) and myrrhone from ChemFaces (Wuhan, China). Commiphora oleogum resins were provided by field experts (Georg Huber, Heppenheim, Germany and Dan Riegler, Hamilton, ON, Canada) and subsequently deposited at the Herbarium of the Botanical Garden of Ulm University, Institute of Systemic Botany and Ecology, Germany (voucher: ULM-24224). For more precise sample information please see Appendix A Table A1. The Commiphora botanical drugs Myrrhinil-Intest® (Batch No. 9100816) and Gugulipid® (Batch No. 1353619) were from Repha GmbH (Langenhagen, Germany) and Natural Organics Inc. (Amityville, NY, USA), respectively.

3.2. Extraction and Hydrodistillation

For extraction, 600 mg of freshly grounded Commiphora oleogum resins were extracted with 4.8 mL MeOH at room temperature for 45 min with continuous stirring. The suspensions were centrifuged for 5 min at 5000× g and the extraction was repeated twice. Finally, the combined supernatants were filtered (0.45 µm, regenerated cellulose) and evaporated to dryness by using a rotary evaporator.
Essential oils were obtained by hydrodistillation of oleogum resins as previously described [23]. Shortly, 100 g of oleogum resin was added to 250 mL water and mixed carefully. For hydrodistillation, the aqueous suspension was heated for 8 h at 120–125 °C with continuous stirring. The essential oil was carefully separated from the aqueous phase with the help of a separating funnel. Additionally, the aqueous phase was subsequently extracted two times with 5 mL n-hexane. The solvent of the combined organic phases was evaporated at 60 °C (water bath) with nitrogen stream.

3.3. HPLC-MS/MS Analysis

The HPLC-MS/MS experiments were carried out on an Agilent 1260 Infinity HPLC system (Agilent, Santa Clara, CA, USA) coupled with an AB API 2000 triple quadrupole mass spectrometer (Applied Biosystem, Foster City, CA, USA) using an electrospray ionization ion source (ESI) in positive ionization mode. Devices were controlled and data were processed by means of Analyst 1.6.1 software (AB Sciex, Framingham, MA, USA).
The chromatographic separation was performed using an analytical reversed-phase HPLC column (Dr. Maisch ReproSil-Pur Basic-C18 HD, 3 µm, 125 × 3 mm; Dr. Maisch GmbH, Ammerbruch, Germany) with a precolumn (Phenomenex SecurityGuard C18, 4 × 3 mm; Phenomenex, Torrance, CA, USA).
By means of Design of Experiments (DoE) a novel method for chromatographic separation of guggulsterones was developed, in which the flow rate, the starting concentration of eluent B, and the gradient slope were optimized. Thus, the flow rate was 600 µL/min, the mobile phase consisted of methanol/water (20/80, v/v) (eluent A) and methanol (eluent B), both acidified with 0.2% acetic acid. Initial conditions were 32% eluent A and 68% eluent B followed by a linear gradient to 95% eluent B over 6.8 min, then 95% eluent B until 11.8 min. Thereafter, a linear gradient to initial conditions until 12.0 min and reequilibration continued until 17.0 min. In order to stabilize the chromatographic system, the column was kept at a temperature of 28 °C. The injection volume was set to 10 µL.
The MS/MS detection was performed in multiple reaction monitoring (MRM) mode with m/z 313.3 (precursor ion) and m/z 97.1 (product ion) as quantifier for (E)-guggulsterone and (Z)-guggulsterone. Moreover, m/z 313.3 (precursor ion) and m/z 109.1 (product ion) were used as qualifier for both guggulsterones. The ions m/z 231.0/83.0 (quantifier) and m/z 231.0/149.1 (qualifier) were used for curzerenone, m/z 229.0/159.0 (quantifier) and m/z 229.0/187.2 (qualifier) for myrrhone, and m/z 215.0/119.1 (quantifier) and m/z 215.0/105.2 (qualifier) for furanoeudesma-1,3-diene. The optimized source parameters and MS tune parameter are listed in Table 7.
To ensure that Commiphora oleogum resins were not mixed with Boswellia oleogum resin, all samples were additionally analyzed for ten boswellic and lupeolic acids namely, α-boswellic acid (α-BA), acetyl-α-boswellic acid (α-ABA), β-boswellic acid (β-BA), acetyl-β-boswellic acid (β-ABA), 11-keto-α-boswellic acid (α-KBA), 11-keto-β-boswellic acid (β-KBA), acetyl-11-keto-α-boswellic acid (α-AKBA), acetyl-11-keto-β-boswellic acid (β-AKBA), lupeolic acid (LA), and acetyl-lupeolic acid (ALA). The boswellic and lupeolic acid analysis by HPLC-MS/MS was carried out as previously described [23,24].

3.4. GC Analysis of Essential Oils

Analysis of essential oils in oleogum resins of different Commiphora species by GC-FID and GC-MS was carried out as described previously in detail [23,45]. The individual compounds were identified by means of their retention indices as calculated from a homologous series of n-alkanes and mass spectra comparison with NIST17 libraries and in-house libraries. Moreover, 2-methoxyisofuranogermacrene and dihydropyrocurzerenone were identified by comparison of retention indices and mass spectra with expert literature [32,46]. Results are expressed by means of internal normalization of the FID chromatogram, without correction factor.

3.5. Analysis of Antiprolferative and Cytotoxic Effects In Vitro

The skin cancer cell lines, epidermoid carcinoma cells A431, malignant melanoma cells RPMI-7951 and SK-MEL-25, and normal human keratinocytes MBU-IM were from the German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany) and cultured as recommended.
Cells were seeded into 96-well plates and treated 24 h later using Tecan D300e digital dispenser (Tecan, Männedorf, Switzerland). After 72 h incubation period, cell viability was analyzed by addition of 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide salt (XTT; AppliChem GmbH, Darmstadt, Germany). Absorbance of the formed orange formazan dye was analyzed with an Infinite M1000 PRO Tecan plate reader (Tecan) at λ = 450 nm with a λ = 630 nm reference filter [47]. For quantification of cell viability, the blank values containing the respective compounds in the according concentration were subtracted and the percentage of viable cell was calculated by normalization to the vehicle control. IC50 values were determined using SigmaPlot 14.0 software (Systat Software Inc., San Jose, CA, USA).
Combination studies of cytotoxic effects of (E)- and (Z)-guggulsterone in human skin cancer cell lines were carried out according to recommendations [42,43] using CalcuSyn (BioSoft, Cambridge, UK). Cell viability after 72 h of treatment analyzed by XTT assay was used as an end point.

3.6. Statistical Analysis

Statistical analysis was performed using Minitab 18 software (Minitab, Munich, Germany), SigmaPlot 14.0 software (Systat Software Inc., San Jose, CA, USA), and Valoo 2.10 software (Applica, Bremen, Germany). All data were tested for normal distribution by the Anderson-Darling test and equality of variances by Levene’s test. Sample groups were compared by one-way analysis of variance (ANOVA) and post hoc by Dunett’s test. Comparison of two sample groups was carried out by Student’s t-test. Results with p < 0.05 were considered as statistically significant.

4. Conclusions

A highly, selective, and accurate method for the simultaneous determination of five phytosteroids and furanosesquiterpenoids in oleogum resins of the genus Commiphora by HPLC-MS/MS has been developed and validated. Additionally, essential oils of the respective oleogum resins were analyzed by GC. The phytochemical profiles were used to classify Commiphora oleogum resins of the species C. myrrha, C. erythraea, C. mukul, C. holtziana, C. confusa, and C. kua as well as unspecified Commiphora resins. Hence, patterns in the phytochemical composition were discovered assisting a chemotaxonomical differentiation among different Commiphora species. Interestingly, a Commiphora oleogum resin from the Ogaden region in Ethiopia comprised guggulsterones, which are unique for C. mukul from the India subcontinent. Considering the guggulsterones isomer’s ratio and essential oil composition, Commiphora from Ogaden in Africa differs considerably from C. mukul suggesting that at least one African Commiphora species produces also phytosteroids such as guggulsterones. Moreover, the study provides evidence for cytotoxic efficacy of Commiphora extracts and essential oils against human epidermoid carcinoma and malignant melanoma cells in vitro. Here, especially C. mukul extract and C. myrrha essential oil exhibited the highest cytotoxicity against all three skin cancer cell lines investigated, but were less toxic to normal keratinocytes. Commiphora preparations and phytochemicals should be investigated more detailed regarding, for example, their systemic toxicity aiming at the development of new anticancer drugs.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/molecules27123903/s1, Figure S1: Mass spectra of (E)-guggulsterone and (Z)-guggulsterone; Figure S2: Mass spectra curzerenone, furanoeudesma-1,3-diene, and myrrhone; Table S1: Design of Experiments (DoE) for optimization of chromatographic parameters for selective and rapid guggulsterone analysis; Table S2: Quantification of (E)-guggulsterone, (Z)-guggulsterone, curzerenone, furanoeudesma-1,3-diene, and myrrhone in Commiphora oleogum resin extracts and botanical drugs; Table S3: Analysis of essential oils in Commiphora oleogum resins; Figure S3: Total wavelength chromatograms (TWC) of Commiphora oleogum resin extracts; Figure S4: Cytotoxicity of Commiphora extracts and essential oils against epidermoid carcinoma cell line A431 and malignant melanoma cell lines RPMI-7951 and SK-MEL-28.

Author Contributions

J.U., S.S., M.S. and T.S. (Tatiana Syrovets) conceived and designed the experiments; J.U., S.S., A.S.-G., M.E.G. and M.S. performed the experiments; J.U., S.S. and M.S. analyzed the data; M.S. and J.U. wrote the original draft; T.S. (Tatiana Syrovets) and T.S. (Thomas Simmet) obtained funding, reviewed and edited the draft. All authors have read and agreed to the published version of the manuscript.

Funding

This work was in part supported by the Academic Center for Complementary and Integrative Medicine (AZKIM), Project KIG-BaWü, Ministerium für Soziales und Integration Baden-Württemberg, Germany.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article and the supplementary materials.

Acknowledgments

We thank Georg Huber and Dan Riegler for providing Commiphora samples and photo material.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds and specimens are available from the authors.

Appendix A

Table A1. Commiphora oleogum resin samples investigated. Specimens of all samples are deposited in the Herbarium of the Botanical Garden, Institute of Systemic Botany and Ecology, Ulm University (Voucher: ULM-25418).
Table A1. Commiphora oleogum resin samples investigated. Specimens of all samples are deposited in the Herbarium of the Botanical Garden, Institute of Systemic Botany and Ecology, Ulm University (Voucher: ULM-25418).
GenusSpeciesOriginHerbarium Specimen No.
CommiphoraC. myrrhaSomalia190425-42
C. erythraeaSomalia190425-43
C. mukulNepal190425-44
C. katafKenya190425-45
C. holtzianaKenya190425-46
C. confusaKenya190425-47
C. kuaYemen (Socotra)190425-48
N/ASomalia (Tarraxo)190425-49
N/AEthiopia (Ogaden)190425-50

References

  1. Hanus, L.O.; Rezanka, T.; Dembitsky, V.M.; Moussaieff, A. Myrrh—Commiphora chemistry. Biomed. Pap. 2005, 149, 3–27. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Martinetz, D.; Lohs, K.; Janzen, J. Weihrauch und Myrrhe: Kulturgeschichte und Wirtschaftliche Bedeutung, Botanik, Chemie, Medizin; Wissenschaftliche Verlangsgesellschaft mbH: Stuttgart, Germany, 1988; Volume 43–88, pp. 101–168. [Google Scholar]
  3. Tucker, A.O. Frankincense and myrrh. Econ. Bot. 1986, 40, 425–433. [Google Scholar] [CrossRef]
  4. Shen, T.; Li, G.H.; Wang, X.N.; Lou, H.X. The genus Commiphora: A review of its traditional uses, phytochemistry and pharmacology. J. Ethnopharmacol. 2012, 142, 319–330. [Google Scholar] [CrossRef]
  5. Shishodia, S.; Harikumar, K.B.; Dass, S.; Ramawat, K.G.; Aggarwal, B.B. The guggul for chronic diseases: Ancient medicine, modern targets. Anticancer Res. 2008, 28, 3647–3664. [Google Scholar]
  6. Ali, M.A. Species-specific molecular signature of Commiphora species of Saudi Arabia inferred from internal transcribed spacer sequences of nuclear ribosomal DNA. Saudi J. Biol. Sci. 2018, 25, 1298–1301. [Google Scholar] [CrossRef]
  7. Cenci, E.; Messina, F.; Rossi, E.; Epifano, F.; Marcotullio, M.C. Antiviral Furanosesquiterpenes from Commiphora erythraea. Nat. Prod. Commun. 2012, 7, 1934578X1200700201. [Google Scholar] [CrossRef] [Green Version]
  8. Urizar, N.L.; Liverman, A.B.; Dodds, D.T.; Silva, F.V.; Ordentlich, P.; Yan, Y.; Gonzalez, F.J.; Heyman, R.A.; Mangelsdorf, D.J.; Moore, D.D. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 2002, 296, 1703–1706. [Google Scholar] [CrossRef]
  9. Urizar, N.L.; Moore, D.D. Gugulipid: A natural cholesterol-lowering agent. Annu. Rev. Nutr. 2003, 23, 303–313. [Google Scholar] [CrossRef] [Green Version]
  10. Szapary, P.O.; Wolfe, M.L.; Bloedon, L.T.; Cucchiara, A.J.; DerMarderosian, A.H.; Cirigliano, M.D.; Rader, D.J. Guggulipid for the treatment of hypercholesterolemia: A randomized controlled trial. JAMA 2003, 290, 765–772. [Google Scholar] [CrossRef] [Green Version]
  11. Ulbricht, C.; Basch, E.; Szapary, P.; Hammerness, P.; Axentsev, S.; Boon, H.; Kroll, D.; Garraway, L.; Vora, M.; Woods, J. Guggul for hyperlipidemia: A review by the Natural Standard Research Collaboration. Complement. Ther. Med. 2005, 13, 279–290. [Google Scholar] [CrossRef]
  12. Schrott, E.; Ammon, H.P.T. Heilfpflanzen der Ayurvedischen und der Westlichen Medizin; Springer: Berlin/Heidelberg, Germany, 2012; Volume 1, pp. 380–381. [Google Scholar]
  13. Tariq, M.; Ageel, A.M.; Al-Yahya, M.A.; Mossa, J.S.; Al-Said, M.S.; Parmar, N.S. Anti-inflammatory activity of Commiphora molmol. Agents Actions 1985, 17, 381–382. [Google Scholar] [CrossRef] [PubMed]
  14. Bellezza, I.; Mierla, A.; Grottelli, S.; Marcotullio, M.C.; Messina, F.; Roscini, L.; Cardinali, G.; Curini, M.; Minelli, A. Furanodien-6-one from Commiphora erythraea inhibits the NF-κB signalling and attenuates LPS-induced neuroinflammation. Mol. Immunol. 2013, 54, 347–354. [Google Scholar] [CrossRef] [PubMed]
  15. Shah, R.; Gulati, V.; Palombo, E.A. Pharmacological properties of guggulsterones, the major active components of gum guggul. Phytother. Res. 2012, 26, 1594–1605. [Google Scholar] [CrossRef] [PubMed]
  16. Langhorst, J.; Varnhagen, I.; Schneider, S.B.; Albrecht, U.; Rueffer, A.; Stange, R.; Michalsen, A.; Dobos, G.J. Randomised clinical trial: A herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis—A double-blind, double-dummy study. Aliment. Pharmacol. Ther. 2013, 38, 490–500. [Google Scholar] [CrossRef]
  17. Shishodia, S.; Aggarwal, B.B. Guggulsterone inhibits NF-κB and IκBα kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J. Biol. Chem. 2004, 279, 47148–47158. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Singh, S.V.; Zeng, Y.; Xiao, D.; Vogel, V.G.; Nelson, J.B.; Dhir, R.; Tripathi, Y.B. Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak. Mol. Cancer Ther. 2005, 4, 1747–1754. [Google Scholar] [CrossRef] [Green Version]
  19. Ijaz, S.; Akhtar, N.; Khan, M.S.; Hameed, A.; Irfan, M.; Arshad, M.A.; Ali, S.; Asrar, M. Plant derived anticancer agents: A green approach towards skin cancers. Biomed. Pharmacother. 2018, 103, 1643–1651. [Google Scholar] [CrossRef] [PubMed]
  20. Ahmed, R.; Wang, Y.H.; Ali, Z.; Smillie, T.J.; Khan, I.A. HPLC method for chemical fingerprinting of guggul (Commiphora wightii)—Quantification of E- and Z-guggulsterones and detection of possible adulterants. Planta Med. 2016, 82, 356–361. [Google Scholar] [CrossRef] [Green Version]
  21. Mesrob, B.; Nesbitt, C.; Misra, R.; Pandey, R.C. High-performance liquid chromatographic method for fingerprinting and quantitative determination of E- and Z-guggulsterones in Commiphora mukul resin and its products. J. Chromatogr. B Biomed. Sci. Appl. 1998, 720, 189–196. [Google Scholar] [CrossRef]
  22. Soni, V.; Swarnkar, P.L.; Tyagi, V.; Pareek, L.K. Variation in E- and Z-guggulsterones of Commiphora wightii. S. Afr. J. Bot. 2010, 76, 421–424. [Google Scholar] [CrossRef] [Green Version]
  23. Schmiech, M.; Ulrich, J.; Lang, S.J.; Büchele, B.; Paetz, C.; St-Gelais, A.; Syrovets, T.; Simmet, T. 11-Keto-α-boswellic acid, a novel triterpenoid from Boswellia spp. with chemotaxonomic potential and antitumor activity against triple-negative breast cancer cells. Molecules 2021, 26, 366. [Google Scholar] [CrossRef]
  24. Schmiech, M.; Lang, S.J.; Werner, K.; Rashan, L.J.; Syrovets, T.; Simmet, T. Comparative analysis of pentacyclic triterpenic acid compositions in oleogum resins of different Boswellia species and their in vitro cytotoxicity against treatment-resistant human breast cancer cells. Molecules 2019, 24, 2153. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. CAS. SciFinder Database. Available online: https://scifinder-n.cas.org/ (accessed on 12 October 2021).
  26. Liu, H.; Lam, L.; Yan, L.; Chi, B.; Dasgupta, P.K. Expanding the linear dynamic range for quantitative liquid chromatography-high resolution mass spectrometry utilizing natural isotopologue signals. Anal. Chim. Acta 2014, 850, 65–70. [Google Scholar] [CrossRef]
  27. DIN 32645; Chemische Analytik; Nachweis-, Erfassungs- und Bestimmungsgrenze; Ermittlung unter Wiederholbedingungen; Begriffe, Verfahren, Auswertung. Beuth: Berlin, Germany, 1994.
  28. Maradufu, A.; Warthen, J.D.J. Furanosesquiterpenoids from Commiphora myrrh oil. Plant Sci. 1988, 57, 181–184. [Google Scholar] [CrossRef]
  29. Marcotullio, M.C.; Santi, C.; Mwankie, G.N.; Curini, M. Chemical composition of the essential oil of Commiphora erythraea. Nat. Prod. Commun. 2009, 4, 1751–1754. [Google Scholar] [CrossRef] [Green Version]
  30. Marcotullio, M.C.; Rosati, O.; Lanari, D. Phytochemistry of Commiphora erythraea: A review. Nat. Prod. Commun. 2018, 13, 1934578X1801300925. [Google Scholar] [CrossRef] [Green Version]
  31. Delay, F.; Ohloff, G. Syntheses and absolute configuration of (E)- and (Z)-a-bisbolenes. Helv. Chim. Acta 1979, 62, 369–377. [Google Scholar] [CrossRef]
  32. Dekebo, A.; Dagne, E.; Sterner, O. Furanosesquiterpenes from Commiphora sphaerocarpa and related adulterants of true myrrh. Fitoterapia 2002, 73, 48–55. [Google Scholar] [CrossRef]
  33. Birkett, M.A.; Abassi, S.A.; Kröber, T.; Chamberlain, K.; Hooper, A.M.; Guerin, P.M.; Pettersson, J.; Pickett, J.A.; Slade, R.; Wadhams, L.J. Antiectoparasitic activity of the gum resin, gum haggar, from the East African plant, Commiphora holtziana. Phytochemistry 2008, 69, 1710–1715. [Google Scholar] [CrossRef] [Green Version]
  34. Asfaw, N.; Sommerlatte, H.; Demissew, S. Uncommon frankincense. Perfum. Flavor. 2019, 44, 47–53. [Google Scholar]
  35. Manguro, L.O.; Ugi, I.; Lemmen, P. Dammarane triterpenes of Commiphora confusa resin. Chem. Pharm. Bull. 2003, 51, 483–486. [Google Scholar] [CrossRef] [Green Version]
  36. Manguro, L.O.; Ugi, I.; Lemmen, P. Further bisabolenes and dammarane triterpenes of Commiphora kua resin. Chem. Pharm. Bull. 2003, 51, 479–482. [Google Scholar] [CrossRef] [Green Version]
  37. Ali, N.A.A.; Wurster, M.; Arnold, N.; Lindequist, U.; Wessjohan, L. Essential oil composition from oleogum resin of soqotraen Commiphora kua. Rec. Nat. Prod. 2008, 2, 70–75. [Google Scholar]
  38. Jiang, Z.; Jacob, J.A.; Loganathachetti, D.S.; Nainangu, P.; Chen, B. β-Elemene: Mechanistic studies on cancer cell interaction and its chemosensitization effect. Front. Pharmacol. 2017, 8, 105. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Li, Y.; Wu, Y.; Li, Y.; Guo, F. Review of the traditional uses, phytochemistry, and pharmacology of Curcuma wenyujin Y. H. Chen et C. Ling. J. Ethnopharmacol. 2021, 269, 113689. [Google Scholar] [CrossRef]
  40. Peng, X.; Zhao, Y.; Liang, X.; Wu, L.; Cui, S.; Guo, A.; Wang, W. Assessing the quality of RCTs on the effect of beta-elemene, one ingredient of a Chinese herb, against malignant tumors. Contemp. Clin. Trials 2006, 27, 70–82. [Google Scholar] [CrossRef] [PubMed]
  41. Wang, Y.; Li, J.; Guo, J.; Wang, Q.; Zhu, S.; Gao, S.; Yang, C.; Wei, M.; Pan, X.; Zhu, W.; et al. Cytotoxic and antitumor effects of curzerene from Curcuma longa. Planta Med. 2017, 83, 23–29. [Google Scholar] [CrossRef] [Green Version]
  42. Tallarida, R.J. An overview of drug combination analysis with isobolograms. J. Pharmacol. Exp. Ther. 2006, 319, 1–7. [Google Scholar] [CrossRef] [Green Version]
  43. Chou, T.C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 2006, 58, 621–681. [Google Scholar] [CrossRef]
  44. Patil, V.D.; Nayak, U.R.; Dev, S. Chemistry of Ayurvedic crude drugs—I: Guggulu (resin from Commiphora mukul)—1: Steroidal constituents. Tetrahedron 1972, 28, 2341–2352. [Google Scholar] [CrossRef]
  45. St-Gelais, A.; Maldonado, E.M.; Saavedra, G.; Siles-Alvarado, S.; Alsarraf, J.; Collin, G.; Pichette, A. Essential oils from Bolivia. XV. Herzogole, an original monoterpene benzodioxole from an essential oil from Pentacalia herzogii (Cabrera) Cuatrec. Molecules 2021, 26, 5766. [Google Scholar] [CrossRef] [PubMed]
  46. Ayyad, S.E.; Hoye, T.R.; Alarif, W.M.; Al Ahmadi, S.M.; Basaif, S.A.; Ghandourah, M.A.; Badria, F.A. Differential cytotoxic activity of the petroleum ether extract and its furanosesquiterpenoid constituents from Commiphora molmol resin. Z. Naturforsch. C J. Biosci. 2015, 70, 87–92. [Google Scholar] [CrossRef] [PubMed]
  47. Schmiech, M.; Lang, S.J.; Ulrich, J.; Werner, K.; Rashan, L.J.; Syrovets, T.; Simmet, T. Comparative investigation of frankincense nutraceuticals: Correlation of boswellic and lupeolic acid contents with cytokine release inhibition and toxicity against triple-negative breast cancer cells. Nutrients 2019, 11, 2341. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Commiphora tree and lead compounds of the genus Commiphora. (a) Tree of the species C. myrrha in Somalia. Picture with friendly permission from Georg Huber. (b) Chemical structures of lead compounds found in Commiphora species: phytosteroids (E)-guggulsterone and (Z)-guggulsterone and furanosesquiterpenoids curzerenone, furanoeudesma-1,3-diene, and myrrhone.
Figure 1. Commiphora tree and lead compounds of the genus Commiphora. (a) Tree of the species C. myrrha in Somalia. Picture with friendly permission from Georg Huber. (b) Chemical structures of lead compounds found in Commiphora species: phytosteroids (E)-guggulsterone and (Z)-guggulsterone and furanosesquiterpenoids curzerenone, furanoeudesma-1,3-diene, and myrrhone.
Molecules 27 03903 g001
Figure 2. Contour plots visualizing the effects of variables A (starting concentration of eluent B) and variable B (slope of gradient) on chromatographic resolution R and mean retention time Ø tR of guggulsterones. Numbers (5–12 and 15) demonstrate the individual experiments (described in detail in Table S1). The level conditions of experiment #8 exhibited the required chromatographic resolution R < 1.5 and a rapid run time with Ø tR < 5 min. (a) Effect of variables A and B on the chromatographic resolution R between (E)-guggulsterone and (Z)-guggulsterone. (b) Effect of variables A and B on the averaged retention time Ø tR of (E)-guggulsterone and (Z)-guggulsterone.
Figure 2. Contour plots visualizing the effects of variables A (starting concentration of eluent B) and variable B (slope of gradient) on chromatographic resolution R and mean retention time Ø tR of guggulsterones. Numbers (5–12 and 15) demonstrate the individual experiments (described in detail in Table S1). The level conditions of experiment #8 exhibited the required chromatographic resolution R < 1.5 and a rapid run time with Ø tR < 5 min. (a) Effect of variables A and B on the chromatographic resolution R between (E)-guggulsterone and (Z)-guggulsterone. (b) Effect of variables A and B on the averaged retention time Ø tR of (E)-guggulsterone and (Z)-guggulsterone.
Molecules 27 03903 g002
Figure 3. Radar charts visualizing the contents of (E)-guggulsterone, (Z)-guggulsterone, curzerenone, furanoeudesma-1,3-diene, and myrrhone in Commiphora oleogum resins from different species and locations as well as two Commiphora botanical drugs, Myrrhinil-Intest® and Gugulipid®. All contents are normalized and logarithmically scaled. (a) Composition of guggulsterones and furanosesquiterpenoids in C. myrrha (blue) and Myrrhinil-Intest® (orange). Annotation and scaling correspond to all other radar charts. (b) C. erythraea. (c) C. mukul (blue) and Gugulipid® (orange). (d) C. kataf. (e) C. holtziana. (f) C. confusa. (g) C. kua. (h) Commiphora oleogum resin from Tarraxo (Somalia). (i) Commiphora oleogum resin from Ogaden (Ethiopia).
Figure 3. Radar charts visualizing the contents of (E)-guggulsterone, (Z)-guggulsterone, curzerenone, furanoeudesma-1,3-diene, and myrrhone in Commiphora oleogum resins from different species and locations as well as two Commiphora botanical drugs, Myrrhinil-Intest® and Gugulipid®. All contents are normalized and logarithmically scaled. (a) Composition of guggulsterones and furanosesquiterpenoids in C. myrrha (blue) and Myrrhinil-Intest® (orange). Annotation and scaling correspond to all other radar charts. (b) C. erythraea. (c) C. mukul (blue) and Gugulipid® (orange). (d) C. kataf. (e) C. holtziana. (f) C. confusa. (g) C. kua. (h) Commiphora oleogum resin from Tarraxo (Somalia). (i) Commiphora oleogum resin from Ogaden (Ethiopia).
Molecules 27 03903 g003
Figure 4. Chromatograms of C. mukul olegum resin. Despite a complex biological matrix, HPLC-MS/MS analysis enabled selective quantification of (E)-guggulsterone and (Z)-guggulsterone. Curzerenone, furanoeudsma-1,3-diene, and myrrhone were not detectable in C. mukul. (a) Total wavelength chromatogram (TWC) with detection at 210 nm, 254 nm, and 280 nm. (b) Multiple reaction monitoring (MRM) chromatogram with m/z 313.3/97.1 as quantifier (blue) and m/z 313.3/109.1 as qualifier (red) for both guggulsterone isomers.
Figure 4. Chromatograms of C. mukul olegum resin. Despite a complex biological matrix, HPLC-MS/MS analysis enabled selective quantification of (E)-guggulsterone and (Z)-guggulsterone. Curzerenone, furanoeudsma-1,3-diene, and myrrhone were not detectable in C. mukul. (a) Total wavelength chromatogram (TWC) with detection at 210 nm, 254 nm, and 280 nm. (b) Multiple reaction monitoring (MRM) chromatogram with m/z 313.3/97.1 as quantifier (blue) and m/z 313.3/109.1 as qualifier (red) for both guggulsterone isomers.
Molecules 27 03903 g004
Figure 5. Chromatograms of C. holtziana olegum resin. HPLC-MS/MS analysis revealed the presence of curzerenone, furanoeudsma-1,3-diene, and myrrhone in C. holtziana, but no guggulsterones. (a) Total wavelength chromatogram (TWC) with detection at 210 nm, 254 nm, and 280 nm. (b) Multiple reaction monitoring (MRM) chromatogram of curzerenone (tR = 4.32 min) with m/z 231.0/83.0 as quantifier (blue) and m/z 231.0/149.0 as qualifier (red). (c) MRM chromatogram of myrrhone (tR = 6.03 min) with m/z 229.0/159.0 as quantifier (blue) and m/z 229.0/187.2 as qualifier (red). (d) MRM chromatogram of furanoeudesma-1,3-diene (tR = 9.22 min) with m/z 215.0/119.1 as quantifier (blue) and m/z 215.0/105.2 as qualifier (red).
Figure 5. Chromatograms of C. holtziana olegum resin. HPLC-MS/MS analysis revealed the presence of curzerenone, furanoeudsma-1,3-diene, and myrrhone in C. holtziana, but no guggulsterones. (a) Total wavelength chromatogram (TWC) with detection at 210 nm, 254 nm, and 280 nm. (b) Multiple reaction monitoring (MRM) chromatogram of curzerenone (tR = 4.32 min) with m/z 231.0/83.0 as quantifier (blue) and m/z 231.0/149.0 as qualifier (red). (c) MRM chromatogram of myrrhone (tR = 6.03 min) with m/z 229.0/159.0 as quantifier (blue) and m/z 229.0/187.2 as qualifier (red). (d) MRM chromatogram of furanoeudesma-1,3-diene (tR = 9.22 min) with m/z 215.0/119.1 as quantifier (blue) and m/z 215.0/105.2 as qualifier (red).
Molecules 27 03903 g005
Figure 6. C. mukul extract and C. myrrha essential oil are more toxic to malignant melanoma cell line RPMI-7951 than to normal human keratinocytes. (a) C. mukul extract. (b) C. myrrha essential oil. Cell viability was analyzed by XTT assay in cells treated for, 72 h. All data were mean ± SEM of three biological samples, each analyzed in triplicates.
Figure 6. C. mukul extract and C. myrrha essential oil are more toxic to malignant melanoma cell line RPMI-7951 than to normal human keratinocytes. (a) C. mukul extract. (b) C. myrrha essential oil. Cell viability was analyzed by XTT assay in cells treated for, 72 h. All data were mean ± SEM of three biological samples, each analyzed in triplicates.
Molecules 27 03903 g006
Table 1. HPLC-MS/MS validation data: Regression equation, limit of detection (LOD), and limit of quantification (LOQ).
Table 1. HPLC-MS/MS validation data: Regression equation, limit of detection (LOD), and limit of quantification (LOQ).
CompoundRegression Equation 1LOD 2LOQ 2
y i = a × c i + b
Slope (a)Offset (b)R2Lin. Test
(E)-Guggulsterone353.62216.70.9997linear2.0 ng/mL7.2 ng/mL
(Z)-Guggulsterone343.52391.10.9994linear1.8 ng/mL6.6 ng/mL
Curzerenone69.9−145.30.9997linear1.6 ng/mL5.7 ng/mL
Furanoeudesma-1,3-diene332.5312.80.9999linear2.3 µg/mL8.4 µg/mL
Myrrhone44.782.30.9992linear2.3 ng/mL8.2 ng/mL
1 Regression equations of 10-point calibration (1–1000 ng/mL or 0.1–500 µg/mL); yi, peak area of the corresponding compound [cps]; ci, concentration of the corresponding compound [ng/mL or µg/mL]; linearity (lin.) test with 5% level of significance. 2 LOD and LOQ according to DIN 32645 on basis of a 7-point calibration (1–100 ng/mL or 0.1–10 µg/mL).
Table 2. HPLC-MS/MS validation data: Precision and recovery.
Table 2. HPLC-MS/MS validation data: Precision and recovery.
CompoundIntraday and Interday Precision 1 (RSD)Recovery 2 [%]
Low Level [%]High Level [%]
IntradayInterdayIntradayInterdayMeanSD
(E)-Guggulsterone3.91.91.40.799.91.5
(Z)-Guggulsterone3.93.51.41.399.80.7
Curzerenone3.52.63.91.7100.81.5
Furanoeudesma-1,3-diene4.12.43.72.598.53.9
Myrrhone3.76.64.23.4101.90.4
1 RSD: relative standard deviation [%]; low level, 50 ng/mL or 50 µg/mL for furanoeudesma-1,3-diene only; high level, 500 ng/mL or 500 µg/mL for furanoeudesma-1,3-diene only; intraday repetitions, n = 5; interday repetitions, n = 4. 2 Method of standard addition; C. mukul extract (50 µg/mL) spiked on three levels (125, 250, and 500 ng/mL) and C. holtziana extract (5 µg/mL and 500 µg/mL) spiked on three levels (50, 250, and 500 ng/mL or 25, 50, and 250 µg/mL).
Table 3. Quantification of (E)-guggulsterone, (Z)-guggulsterone, curzerenone, furanoeudesma-1,3-diene, and myrrhone in Commiphora oleogum resins. Analysis by HPLC-MS/MS, in duplicates. Contents below limit of quantification or detection (<LOQ/<LOD) are indicated as “-”.
Table 3. Quantification of (E)-guggulsterone, (Z)-guggulsterone, curzerenone, furanoeudesma-1,3-diene, and myrrhone in Commiphora oleogum resins. Analysis by HPLC-MS/MS, in duplicates. Contents below limit of quantification or detection (<LOQ/<LOD) are indicated as “-”.
Species (Origin)Contents of Guggulsterones and Furanosesquiterpenoids in
Commiphora Oleogum Resins [µg/mg]
(E)-Guggulsterone(Z)-GuggulsteroneCurzerenoneFuranoeudesma-1,3-dieneMyrrhone
C. myrrha (Somalia)--0.02687.7100.001
C. erythraea (Somalia)--1.740-0.602
C. mukul (Nepal)1.0592.470---
C. kataf (Kenya)--1.455-2.207
C. holtziana (Kenya)--3.37923.0520.126
C. confusa (Kenya)--0.004--
C. kua (Socotra, Yemen)-----
C. from Tarraxo (Somalia)--9.518-0.030
C. from Ogaden (Ethiopia)0.2720.1742.206-0.868
Table 4. Chemical composition of Commiphora oleogum resin essential oils. Relative quantification by gas chromatography and flame ionization detection (GC-FID) using internal normalization, areas in uncorrected %. List of main components (area > 1%). Hydrodistillation of Commiphora oleogum resin from Tarraxo (Somalia) yielded no essential oil and consequently, no GC analysis is shown. Traces tr < 0.05%. Complete data are shown in Supplementary Materials, Table S3.
Table 4. Chemical composition of Commiphora oleogum resin essential oils. Relative quantification by gas chromatography and flame ionization detection (GC-FID) using internal normalization, areas in uncorrected %. List of main components (area > 1%). Hydrodistillation of Commiphora oleogum resin from Tarraxo (Somalia) yielded no essential oil and consequently, no GC analysis is shown. Traces tr < 0.05%. Complete data are shown in Supplementary Materials, Table S3.
CompoundC. myrrha (Somalia)C. erythraea (Somalia)C. mukul (Nepal)C. kataf
(Kenya)
C. holtziana (Kenya)C. confuse (Kenya)C. kua
(Socotra, Yemen)
C. from
Ogaden
(Ethiopia)
α-Thujene-tr0.20.20.19.0-tr
α-Pinene-0.58.55.80.839.5tr0.5
3,7,7-Trimethylcyclohepta-1,3,5-triene--2.2--tr--
β-Pinene-0.12.03.50.18.9-0.1
Sabinene-tr0.20.3tr1.1-tr
Δ3-Carene-tr29.8tr---tr
para-Cymene-0.12.10.20.110.0-0.1
Limonene0.10.11.20.20.11.10.10.1
β-Thujone----tr1.0--
trans-Pinocarveol--0.30.30.12.0trtr
α-Phellandren-8-ol-tr0.30.2-1.6-tr
Terpinen-4-ol-tr1.00.1tr4.5trtr
meta-Cymen-8-ol--1.2-----
α-Terpineol-tr1.30.1-1.0-tr
Myrtenol--0.20.2-1.0tr-
Verbenone-tr1.30.1tr1.6trtr
δ-Elemene2.01.1-25.11.8-0.91.8
α-Terpinyl acetate--1.1--0.1--
α-Copaene0.41.30.11.42.2tr1.50.6
β-Bourbonene1.25.2-3.71.3-0.92.1
β-Elemene9.111.10.14.79.6tr0.912.8
Longifolene--24.3-----
cis-α-Bergamotene0.2--1.20.5--0.1
β-Caryophyllene0.71.10.71.20.9-7.71.0
β-Copaene0.41.1-1.00.4-0.30.7
γ-Elemene2.71.1-0.51.8-0.23.8
trans-α-Bergamotene0.11.8--0.3-0.40.9
α-Humulene0.50.70.11.00.5-3.90.7
Allo-Aromadendrene0.10.3-0.30.2-3.80.2
cis-Cadina-1(6),4-diene-0.1-0.1--1.70.2
γ-Muurolene0.21.7-1.60.6-2.01.0
Germacrene D3.31.2-13.71.8-1.58.3
β-Selinene1.11.9-2.11.8-1.21.1
α-Selinene1.22.2-0.91.8-1.81.3
Curzerene29.737.8--18.7-tr32.6
(Z)-α-Bisabolene-4.8-----0.2
β-Bisabolene-1.20.1----0.1
γ-Cadinene0.10.9-1.20.4-24.02.0
δ-Cadinene0.42.3tr1.70.9-8.91.4
α-Cadinene-0.2-0.2--1.90.1
α-Elemol0.21.1-0.50.4-0.11.1
Germacrene B4.61.3-0.72.6-0.34.9
Curzerenone0.60.3-2.62.2-0.12.7
10-epi-Cubenol-0.1-0.3--3.30.2
Furanoeudesma-1,3-diene17.4---23.9-tr-
Lindestrene8.7---6.5-tr-
τ-Cadinol0.20.2-0.60.2-16.90.6
Furanodiene0.41.1--0.4---
Germacrone0.40.3-0.20.3--1.8
2-Methoxyfuranodiene1.1---0.4---
Table 5. Cytotoxic efficacies of Commiphora extracts and essentail oils against the epidermoid carcinoma cell line A431 and the malignant melanoma cells lines RPMI-7951 and SK-MEL-28. Half maximal inhibitory concentrations (IC50) are given in µg/mL, and for pure compounds, additionally in brackets as µM. XTT assay, 72 h. All data were mean ± SEM of three biological samples, each analyzed in triplicates.
Table 5. Cytotoxic efficacies of Commiphora extracts and essentail oils against the epidermoid carcinoma cell line A431 and the malignant melanoma cells lines RPMI-7951 and SK-MEL-28. Half maximal inhibitory concentrations (IC50) are given in µg/mL, and for pure compounds, additionally in brackets as µM. XTT assay, 72 h. All data were mean ± SEM of three biological samples, each analyzed in triplicates.
SamplesIC50, µg/mL (µM)
A431RPMI-7951SK-MEL-28
ExtractsC. myrrha11.7 ± 0.96.1 ± 0.511.9 ± 0.8
C. erythraea17.3 ± 1.711.5 ± 0.720.4 ± 1.1
C. mukul7.6 ± 1.02.9 ± 0.710.9 ± 1.5
C. kataf8.4 ± 0.73.7 ± 1.511.4 ± 2.7
C. holtziana21.4 ± 1.67.5 ± 1.615.4 ± 3.2
C. confusa11.1 ± 1.25.6 ± 0.313.2 ± 0.6
C. kua14.6 ± 2.410.6 ± 1.314.3 ± 2.1
C. from Tarraxo18.6 ± 1.94.3 ± 0.723.4 ± 1.6
C. from Ogaden13.1 ± 1.56.6 ± 0.814.4 ± 2.1
Essential oilsC. myrrha6.4 ± 0.26.3 ± 0.89.5 ± 1.7
C. erythraea9.7 ± 0.58.7 ± 1.012.5 ± 2.4
C. mukul20.2 ± 0.820.2 ± 4.237.2 ± 4.5
C. kataf10.5 ± 0.59.9 ± 2.019.2 ± 1.0
C. holtziana10.1 ± 0.99.0 ± 0.814.9 ± 1.7
C. confusa15.9 ± 1.517.0 ± 2.322.7 ± 1.9
C. kua14.2 ± 3.19.3 ± 0.722.3 ± 0.6
C. from Ogaden8.7 ± 1.15.2 ± 0.220.3 ± 2.5
Lead compounds(E)-Guggulsterone12.6 ± 1.6 (40.3 ± 5.3)3.7 ± 0.6 (11.7 ± 1.9)11.1 ± 1.1 (35.5 ± 3.4)
(Z)-Guggulsterone18.9 ± 1.2 (60.4 ± 3.7)6.4 ± 0.6 (20.5 ± 2.0)10.7 ± 0.8 (34.2 ± 2.6)
Curzerenone23.9 ±5.1 (103.7 ± 22.0)17.5 ± 5.2 (76.1 ± 22.6)23.1 ± 3.0 (100.5 ± 13.0)
Furanoeudesma-1,3-diene9.9 ± 0.1 (46.2 ± 0.2)7.1 ± 0.8 (33.3 ± 3.6)12.0 ± 0.3 (55.9 ± 1.2)
Myrrhone35.4 ± 4.3 (155.0 ± 19.0)6.8 ± 2.5 (29.9 ± 11.1)14.8 ± 11.8 (65.0 ± 51.8)
Botanical drugsMyrrhinil-Intest®317.9 ± 22.1204.2 ± 5.8300.8 ± 6.2
Gugulipid®41.3 ± 0.327.3 ± 3.335.7 ± 0.9
Positive controlsCisplatin10.7 ± 7.0 (35.8 ± 23.3)10.7 ± 3.8 (35.8 ± 12.7)49.6 ± 6.2 (165.5 ± 28.3)
5-Fluorouracil1.0 ± 0.3 (7.4 ± 2.1)12.9 ± 4.1 (99.1 ± 31.7)161.9 ± 81.3 (1245.0 ± 624.9)
Table 6. Combination studies of cytotoxic effects of (E)- and (Z)-guggulsterones in human skin cancer cell lines. Combination index (CI) at three guggulsterone effective doses was analyzed by XTT in cells treated for 72 h. All data were mean ± SEM of three biological samples, each analyzed in triplicates.
Table 6. Combination studies of cytotoxic effects of (E)- and (Z)-guggulsterones in human skin cancer cell lines. Combination index (CI) at three guggulsterone effective doses was analyzed by XTT in cells treated for 72 h. All data were mean ± SEM of three biological samples, each analyzed in triplicates.
Effective Dose (ED)Combination Index (CI)
A431RPMI-7951SK-MEL-28
ED501.15 ± 0.040.73 ± 0.691.13 ± 0.21
ED751.24 ± 0.051.08 ± 0.131.33 ± 0.24
ED901.25 ± 0.051.20 ± 0.471.04 ± 0.27
Range of CI and description: <0.1 very strong synergism, 0.1–0.3 strong synergism, 0.3–0.7 synergism, 0.7–0.85 moderate synergism, 0.85–0.90 slight synergism, 0.9–1.1 nearly additive, 1.1–1.2 slight antagonism, 1.2–1.45 moderate antagonism, 1.45–3.3 antagonism, 3.3–10 strong antagonism, and >10 very strong antagonisms [43].
Table 7. Source and MS tune parameters for quantification of (E)-guggulsterone, (Z)-guggulsterone, curzerenone, myrrhone, and furanoeudesma-1,3-diene by MS/MS.
Table 7. Source and MS tune parameters for quantification of (E)-guggulsterone, (Z)-guggulsterone, curzerenone, myrrhone, and furanoeudesma-1,3-diene by MS/MS.
ParametersQuantifier (Qualifier)
GuggulsteronesCurzerenoneMyrrhoneFuranoeudesma-1,3-dien
Q1 (precursor ion)m/z 313.3 (313.3)m/z 231.0 (231.0)m/z 229.0 (229.0)m/z 215.0 (215.0)
Q3 (product ion)m/z 97.1 (109.1)m/z 83.0 (149.0)m/z 159.0 (187.2)m/z 119.1 (105.2)
Curtain gas (CUR)55.0 psi
Collision gas (CAD)2 psi
Ionspray voltage (IS)4800 V
Temperature (TEM)400 °C
Ion source gas 1 (GS1)30 psi
Ion source gas 2 (GS2)80 psi
Declustering potential (DP)40 V (40 V)30 V (30 V)60 V (60 V)40 V (40 V)
Focusing potential (FP)140 V (160 V)60 V (80 V)180 V (140 V)80 V (80 V)
Entrance potential (EP)10 V (10 V)
Collision pnergy (CE)32 V (30 V)24 V (20 V)44 V (36 V)36 V (36 V)
Collision cell exit potential (CXP)6 V (6V)
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ulrich, J.; Stiltz, S.; St-Gelais, A.; El Gaafary, M.; Simmet, T.; Syrovets, T.; Schmiech, M. Phytochemical Composition of Commiphora Oleogum Resins and Their Cytotoxicity against Skin Cancer Cells. Molecules 2022, 27, 3903. https://doi.org/10.3390/molecules27123903

AMA Style

Ulrich J, Stiltz S, St-Gelais A, El Gaafary M, Simmet T, Syrovets T, Schmiech M. Phytochemical Composition of Commiphora Oleogum Resins and Their Cytotoxicity against Skin Cancer Cells. Molecules. 2022; 27(12):3903. https://doi.org/10.3390/molecules27123903

Chicago/Turabian Style

Ulrich, Judith, Svenja Stiltz, Alexis St-Gelais, Menna El Gaafary, Thomas Simmet, Tatiana Syrovets, and Michael Schmiech. 2022. "Phytochemical Composition of Commiphora Oleogum Resins and Their Cytotoxicity against Skin Cancer Cells" Molecules 27, no. 12: 3903. https://doi.org/10.3390/molecules27123903

Article Metrics

Back to TopTop